Nuron Biotech Inc Email Format
Biotechnology ResearchUnited States11-50 Employees
Nuron Biotech markets and develops vaccines for the prevention and treatment of infectious diseases. We have commercial operations in Europe and around the globe through which we currently market Meningitec. Our lead development candidate is NU300, a Haemophilus influenzae type b conjugate vaccine (formerly marketed by Wyeth as HibTITER® ).